Testing a new contrast agent for ovarian mass ultrasound
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial is testing an investigational contrast agent (FRD001) to see if it improves ultrasound images of suspicious ovarian masses. The goal is to help doctors better tell if a mass is cancerous or not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 75 years old.
- You have at least one ovarian cyst or solid mass that hasn't been treated yet.
- Your overall health is good enough that you can likely live at least 3 months.
- Your blood counts, liver and kidney function, and heart function meet certain lab values.
- You are willing to use effective birth control during the study (if you could become pregnant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This laboratory study uses ovarian cancer fluid collected during surgery to test possible new treatments on cancer and immune cells. It may help researchers find better treatment options in ovarian cancer.
This trial uses a special ultrasound technique to get better images of ovarian growths before surgery. The goal is to improve detection and help plan the best treatment.
This study is testing a new blood test that may help detect ovarian cancer earlier. Researchers want to see if it can tell the difference between people with ovarian cancer and those without it.
This trial tests if a special ultrasound with contrast dye can better diagnose ovarian torsion (twisted ovary). It may help women get faster, more accurate treatment.
This trial tests a new drug (DC05F01) for people with ovarian cancer that has come back after platinum treatment, or for those with other advanced solid tumors that haven't responded to standard therapies. It aims to see if the drug is safe and effective.
This study checks how well a specific ultrasound-based scoring tool can tell the difference between harmless (non-cancer) and harmful (cancer) ovarian masses during pregnancy. If you have a cyst or mass that’s at least 5 cm, your scan details may be used to validate the tool.
Hear when a new Ovary Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.